Infinity Pharmaceuticals, Inc.
INFIQ · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $50 | $193 | $127 | $55 |
| - Cash | $38 | $81 | $29 | $22 |
| + Debt | $48 | $51 | $24 | $32 |
| Enterprise Value | $59 | $163 | $123 | $64 |
| Revenue | $3 | $2 | $2 | $3 |
| % Growth | 39.6% | 8.1% | -43.6% | – |
| Gross Profit | $1 | $1 | $1 | -$4 |
| % Margin | 39.7% | 39.7% | 39.7% | -139.7% |
| EBITDA | -$44 | -$45 | -$38 | -$44 |
| % Margin | -1,686.5% | -2,400.5% | -2,185.2% | -1,453.9% |
| Net Income | -$44 | -$45 | -$40 | -$47 |
| % Margin | -1,711.1% | -2,436.1% | -2,355.6% | -1,543.4% |
| EPS Diluted | -0.5 | -0.53 | -0.68 | -0.83 |
| % Growth | 5.7% | 22.1% | 18.1% | – |
| Operating Cash Flow | -$42 | -$41 | -$36 | -$42 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$2 |
| Free Cash Flow | -$42 | -$41 | -$36 | -$44 |